- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
Patent holdings for IPC class A61K 31/7048
Total number of patents in this class: 4321
10-year publication summary
|
324
|
366
|
356
|
361
|
403
|
438
|
497
|
463
|
388
|
93
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Boehringer Ingelheim International GmbH | 4629 |
55 |
| Société des Produits Nestlé S.A. | 9672 |
50 |
| The Board of Trustees of the University of Illinois | 2623 |
34 |
| Suntory Holdings Limited | 1846 |
31 |
| Boehringer Ingelheim Vetmedica GmbH | 1290 |
28 |
| Phoenix Biotechnology, Inc. | 58 |
26 |
| Massachusetts Institute of Technology | 9795 |
25 |
| Hayashibara Co., Ltd. | 159 |
25 |
| Shenyang Fuyang Pharmaceutical Technology Co., Ltd. | 35 |
25 |
| The Regents of the University of California | 18943 |
24 |
| Korea Research Institute of Bioscience and Biotechnology | 1027 |
23 |
| Evonik Operations GmbH | 3879 |
22 |
| AMOREPACIFIC Corporation | 2606 |
21 |
| GW Research Limited | 402 |
20 |
| RedHill Biopharma Ltd. | 96 |
20 |
| Boehringer Ingelheim Animal Health USA Inc. | 507 |
20 |
| Galderma Holding S.A. | 711 |
20 |
| The Brigham and Women's Hospital, Inc. | 2087 |
19 |
| Galderma S.A. | 174 |
19 |
| Insmed Incorporated | 207 |
19 |
| Other owners | 3795 |